Objective: To determine seroprevalence and markers of infectivity for HSV-1 and HSV-2 in semen donors and donor candidates. Design: The study group consisted of 24 healthy semen donors and donor candidates being evaluated at a national sperm bank. Following a comprehensive patient history interview, all subjects received a complete physical examination and screen for sexually transmitted diseases (STDs). After obtaining informed consent, donor sera were tested for type-specific antibodies to HSV-1 and HSV-2 and semen specimens were cultured and PCR amplified for HSV. Materials/Methods: Semen and sera specimens collected at the sperm bank were shipped to a university clinical microbiology laboratory in liquid nitrogen vapors for the HSV testing. Specimens were allowed to thaw and were thoroughly mixed prior to analysis. Culture and PCR for HSV were performed on all donor and candidate semen specimens and all sera were tested for antibodies to HSV-1 and HSV-2. Semen specimens were cultured for HSV using a tube MRC-5 fibroblast cell line and read for cytopathic effect until 21 days. DNA was extracted from the semen of all culture-negative specimens using the MasterPure™ rapid desalting technique and amplified with HSV-1 and HSV-2 specific primers using buffer L in the FailSafe PCR system. Sera were tested by type specific EIA using the MRL IgG Immunoblot test kit, permitting simultaneous assessment of serostatus to both HSV-1 and HSV-2. Results: Fourteen of the 24 (58.3%) specimens had antibodies to neither HSV subtype, 6 of the 24 (25%) specimens had only HSV-1 type-specific antibodies and 4 of the 24 specimens (16.7%) had type-specific antibodies for both HSV-1 and HSV-2. None of the 24 (0%) specimens had only HSV-2 type-specific antibodies. All semen specimens were negative by both culture and Polymerase Chain Reaction for HSV. Conclusions: Although 16.7% of the study group had type-specific antibodies to both HSV-1 and HSV-2, and 25.0% had antibodies to HSV-1 only, none demonstrated actual semen infectivity by PCR or culture. Although most cases of HSV-2 represent genital herpes, most cases of HSV-1 do not. Our preliminary data demonstrate that neither herpes virus was detected in the semen of the donors suggesting that patient history, physical examination and STD screening are sufficient in eliminating potentially infectious individuals from the donor pool. However, HSV-1 and HSV-2 seropositivity should initiate discussion regarding symptoms of subclinical HSV genitalis and all symptomatic donors should be cultured to eliminate the risk of collecting HSV contaminated semen Supported by: Women’s Health Initiative of the Chandler Medical Center Research Fund, the University of Kentucky, Lexington, KY 40536.
Read full abstract